900000000000526001: REPLACED BY association reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Association type\Historical association reference set (foundation metadata concept)\REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module

900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
REPLACED BY association reference set (foundation metadata concept)	Is a	Historical association reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	targetComponentId
Hydrazide antituberculosis agent	Antituberculosis agent
Hydrazide antituberculosis drug adverse reaction	Isoniazid adverse reaction
Hydrocephalic disproportion NOS	Hydrocephalic disproportion
Hydrocephalic disproportion unspecified	Hydrocephalic disproportion
Hydrochlorothiazide + quinapril hydrochloride	Product containing hydrochlorothiazide and quinapril (medicinal product)
Hydrochlorothiazide + quinapril hydrochloride 12.5mg/10mg tablet	Hydrochlorothiazide 12.5 mg and quinapril (as quinapril hydrochloride) 10 mg oral tablet
Hydrochlorothiazide 25mg	Hydrochlorothiazide 25 mg oral tablet
Hydrocortisone 1% + Pramocaine 1% conventional release rectal foam	Hydrocortisone and pramocaine only product
Hydrocortisone 1% + Pramocaine 1% foam enema	Hydrocortisone and pramocaine only product
Hydrocortisone 100mg powder and solvent for injection solution vial	Hydrocortisone (as hydrocortisone sodium succinate) 100 mg powder for solution for injection vial
Hydrocortisone 100mg/60mL	Product containing precisely hydrocortisone 1.67 milligram/1 milliliter conventional release rectal suspension (clinical drug)
Hydrocortisone 100mg/60mL enema	Product containing precisely hydrocortisone 1.67 milligram/1 milliliter conventional release rectal suspension (clinical drug)
Hydrocortisone 2% topical lotion	Hydrocortisone acetate 20 mg/mL cutaneous lotion
Hydrocortisone acetate 1% eye drops	Hydrocortisone 10 mg/mL eye solution
Hydrocortisone acetate 2.5% cream	Product containing precisely hydrocortisone 25 milligram/1 milliliter conventional release cutaneous cream (clinical drug)
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops	Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution
Hydrocortisone cypionate 10mg/5mL suspension	Product containing precisely hydrocortisone 2 milligram/1 milliliter conventional release oral suspension (clinical drug)
Hydrocortisone/neomycin cream	Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream
Hydrolyase	Hydrolyase
Hydromorphone hydrochloride 100% powder	Hydromorphone only product
Hydromorphone hydrochloride 12mg m/r capsule	Product containing only hydromorphone in oral dose form (medicinal product form)
Hydromorphone hydrochloride 12mg prolonged-release oral capsule	Product containing only hydromorphone in oral dose form (medicinal product form)
Hydromorphone hydrochloride 1mg/mL injection solution ampule	Hydromorphone hydrochloride 1 mg/mL solution for injection
Hydromorphone hydrochloride 32mg m/r capsule	Product containing only hydromorphone in oral dose form (medicinal product form)
Hydromorphone hydrochloride 32mg prolonged-release oral capsule	Product containing only hydromorphone in oral dose form (medicinal product form)
Hydromorphone hydrochloride 4mg/mL injection solution ampule	Hydromorphone hydrochloride 4 mg/mL solution for injection
Hydrous wool fat+zinc oxide 4/8% conventional release cutaneous cream	Lanolin and zinc oxide only product in cutaneous dose form
Hydrous wool fat+zinc oxide 4/8% cream	Lanolin and zinc oxide only product in cutaneous dose form
Hydroxocobalamin 1mg/mL injection 1mL ampule	Product containing precisely hydroxocobalamin (as hydroxocobalamin acetate) 1 milligram/1 milliliter conventional release solution for injection (clinical drug)
Hydroxocobalamin 2.5g powder for conventional release solution for injection vial	Product containing only hydroxocobalamin in parenteral dose form (medicinal product form)
Hydroxocobalamin 2.5g powder for injection solution vial + diluent	Product containing only hydroxocobalamin in parenteral dose form (medicinal product form)
Hydroxyethylcellulose 0.44% conventional release eye drops	Product containing only hyetellose (medicinal product)
Hydroxyethylcellulose 0.44% single-use eye drops	Product containing only hyetellose (medicinal product)
Hydroxypropyl methylcellulose 0.32% conventional release eye drops	Hypromellose 3.2 mg/mL eye solution
Hydroxypropyl methylcellulose 0.32% single-use eye drops	Hypromellose 3.2 mg/mL eye solution
Hydroxypropylmethylcellulose 2% eye drops	Product containing precisely hypromellose 2 milligram/1 milliliter conventional release eye solution (clinical drug)
Hymenoptera species	Order Hymenoptera (organism)
Hyoscine butylbromide allergy	Allergy to hyoscine
Hyoscine hydrobromide 0.125% eye drops	Hyoscine (as hyoscine hydrobromide) 1.25 mg/mL eye solution
Hyoscine hydrobromide 0.25% eye drops	Product containing precisely scopolamine (as scopolamine hydrobromide) 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)
Hyoscine hydrobromide 0.5% eye drops	Hyoscine (as hyoscine hydrobromide) 5 mg/mL eye solution
Hyoscine hydrobromide allergy	Allergy to hyoscine
Hyoscyamine sulfate 0.031mg/1 mL	Hyoscyamine only product
Hyoscyamine sulfate 0.125mg/5mL elixir	Hyoscyamine sulfate 25 microgram/mL oral solution
Hyoscyamine sulfate 0.125mg/5mL liquid	Hyoscyamine sulfate 25 microgram/mL oral solution
Hyoscyamine sulfate 0.125mg/mL liquid	Hyoscyamine sulfate 25 microgram/mL oral solution
Hyperalphaglobulinemia	Hyperalphaglobulinaemia
Hyperbetaglobulinemia	Hyperbetaglobulinemia
Hypercalcemia caused by thiazide AND vitamin A	Hypercalcemia caused by thiazide and/or retinol (disorder)
Hyperchromia	Hyperchromatism
Hypercupremia	Blood copper level above reference range
Hypercupremia	Blood copper level above reference range
Hyperglobulinemia	Hyperglobulinemia
Hyperglycemia clinical management plan	Hyperglycemia clinical management plan
Hyperglycemia self management plan	Hyperglycemia self management plan
Hyperhidrosis, premature cavities and premolar aplasia	Book syndrome (disorder)
Hyperinsulinemia due to benign insulinoma	Hyperinsulinemia due to malignant insulinoma
Hyperinsulinemia due to insulinoma	Hyperinsulinemia due to malignant insulinoma
Hyperlipidemia clinical management plan	Hyperlipidaemia clinical management plan
Hypermenorrhea	Menorrhagia (finding)
Hypermobility	Musculoskeletal hypermobility
Hyperpyrexia	Hyperpyrexia (finding)
Hypersomnolence caused by substance	Drug-induced hypersomnia
Hypertension clinical management plan	Hypertension clinical management plan (record artifact)
Hypertensive ischemic ulcer	Ischemic ulcer of skin due to arterial hypertension (disorder)
Hyperthermia in newborn, unspecified	Hyperthermia in newborn
Hypertonic saline	Sodium chloride only product
Hypertrichosis and acromegaloid facial appearance syndrome	Cantu's syndrome
Hypertrichosis universalis	Congenital hypertrichosis
Hypertrophic cardiomyopathy associated with another disorder	Hypertrophic cardiomyopathy due to disorder
Hypertrophic cardiomyopathy secondary to Friedreich's ataxia	Hypertrophic cardiomyopathy due to Friedreich ataxia
Hypertrophic cardiomyopathy secondary to hyperthyroidism	Hypertrophic cardiomyopathy due to hyperthyroidism
Hypertrophic cardiomyopathy secondary to neuromuscular disorder	Hypertrophic cardiomyopathy due to neuromuscular disorder
Hypertrophy of bone	External hyperostosis
Hypertrophy of bone and cartilage	External hyperostosis
Hypertrophy of cartilage	Hypertrophy
Hypnotic dependence with current use	Hypnotic dependence (disorder)
Hypoactive sexual desire disorder	Lack or loss of sexual desire
Hypoalphaglobulinemia	Hypoalphaglobulinaemia
Hypobetaglobulinemia	Hypoalphaglobulinaemia
Hypoglobulinemia	Hypoglobulinaemia
Hypoglycemia clinical management plan	Hypoglycemia clinical management plan (record artifact)
Hypoglycemia self management plan	Hypoglycaemia self management plan
Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Woodhouse Sakati syndrome
Hypoparathyroidism - autosomal dominant	Autosomal dominant familial isolated hypoparathyroidism (disorder)
Hypopharyngeal TNM finding	American Joint Committee on Cancer allowable value
Hypophysectomy by other specified approach	Hypophysectomy
Hyposensitivity	Hyposensitivity
Hypospadias, balanic	Glanular hypospadias
Hypospadias, hypertelorism, coloboma, deafness syndrome	BSG syndrome
Hypothyroidism clinical management plan	Hypothyroidism clinical management plan
Hypotonic artificial tears eye drops	Medicinal product categorised by therapeutic role
Hypromellose eye drops allergy	Allergy to hypromellose
Hysterical cataplexy	Cataplexy
Hysterical gait	Functional gait abnormality
Hystrix ichthyosis with deafness	Keratitis ichthyosis and deafness syndrome (disorder)
IUD - NOS	Intrauterine contraceptive device
Iatrogenic tattoo	Iatrogenic tattoo
Ibandronic acid 1mg/mL injection solution 2mL vial	Product containing precisely ibandronic acid (as ibandronate sodium) 1 milligram/1 milliliter conventional release solution for injection (clinical drug)
Ibandronic acid 1mg/mL injection solution 3mL prefilled syringe	Product containing precisely ibandronic acid (as ibandronate sodium) 1 milligram/1 milliliter conventional release solution for injection (clinical drug)
Ibandronic acid 1mg/mL injection solution 6mL vial	Product containing precisely ibandronic acid (as ibandronate sodium) 1 milligram/1 milliliter conventional release solution for injection (clinical drug)

Start Previous Page 61 of 163 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001156010	REPLACED BY association reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001157018	REPLACED BY association reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)